progress in the treatment of alk-positive non-small cell lung cancer
Published 8 years ago • 307 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
2:00
updated data from phase 2 study of alectinib in alk–positive non–small–cell lung cancer
-
1:01
targeting alk rearrangements in non-small cell lung cancer
-
3:53
how to maximize clinical benefits for patients with alk-positive non-small cell lung cancer
-
3:34
alk-positive nsclc: the role of treatment selection and sequencing
-
2:37
crown: lorlatinib in treatment-naïve patients with alk-positive advanced nsclc
-
1:25
updates and unmet needs in alk-mutated lung cancer
-
4:37
development of alk inhibitors in advanced non-small cell lung cancer
-
1:02
blood tests for identifying and monitoring alk-positive non-small cell lung cancer
-
0:56
nautika1: safety and tolerability of neoadjuvant alectinib in alk-positive nsclc
-
3:26
evolving options in first line treatment of alk positive non small cell lung cancer nsclc
-
9:49
alk-positive non-small cell lung cancer (nsclc)
-
2:34
cns metastasis in alk positive lung cancer
-
1:24
choosing the best alk inhibitor for lung cancer
-
51:59
facilitating progress in the treatment of sclc
-
22:10
first and second generation alk inhibitors for the treatment of lung cancer
-
4:31
emerging applications of liquid biopsy in non-small-cell lung cancer
-
13:28
debate: alk positive nsclc - front line therapy - crizotinib
-
1:05
dr. aggarwal on emerging treatment approaches in alk nsclc
-
6:51
progression in alk nsclc after frontline therapy